This Study Was Performed In 97 Hemodialysis Patients (85 On Hd And 12 On Capd) To Investigate The Possible Correlation Between B2-M And Hemodialysis-Related Amyloidosis Syndromes (Hra-S); Differences In B2-M And Hra Behavior Between Patients Hemodialysed With Cellulose And Synthetic Membranes Were Also Included In The Present Study. Data Indicate That B2-M Levels Are Not Correlated With Dialysis Length Or With The Type Of Membrane Used For The Dialysis. On The Contrary, In 16 Patients With The Carpal Tunnel Syndrome, A Significant Correlation Was Found Between The Cts, The Dialysis Length And The Type Of Membrane (Greater Incidence With Cellulosic Membranes).
MessnerR.P.. B2 microglobulin: an old molecule assumes a new look.J Lab Clin Med1984; 104: 141.
2.
ZingraffJ., and DruekeT.. Can the nephrologist prevent dialysis related amyloidosis?Am J Kidney Dis1991; 18: 1.
3.
BordoniE., Di BellaP., GaffiG., LogulloF., DanniM., PerilliA., MioliV.. Polineuropatia e sindrome del tunnel carpale negli uremici in terapia conservativa.Nefrologia, Dialisi e Trapianti.Milano: Wichtig Ed1990; 501.
BrownE.A., ArnoldI.R., GowerP.E.. Dialysis arthropathy: complications of long-term treatment with haemodialysis.Br Med J1986; 292: 163.
17.
LonnemannG., BingelM., KochK.M., ShaldonS., DinarelloC.A.. Plasma lnterleukin-1 activity in humans undergoing haemodialysis with regenerated cellulosic membranes.Lymphokine Res1987; 6: 63.
18.
HerbelinA., Thu NguyenA.. Zingraff J, Urena P, Descamps-Latsche P. Influence of uremia and haemodialysis on circulating lnterleukin-1 and tumor necrosis factor-alpha.Kidney Int1990; 37: 116.
19.
OtaK., KitanoU., MiyasakaN.. Clinical and Pathophysiological aspects of dialysis-associated amyloidosis.Nephrol Dial Transpl1989; 4(suppl.) 7.
20.
FenvesA.Z., EmmetM., WhiteM.G.. Carpal Tunnel Syndrome with cystic bone lesions secondary to amyloidosis in chronic haemodialysis patients.Am J Kidney Dis1986; 7: 130.
21.
SpertiniF., WautersJ.P., PoulenasJ.. Carpal Tunnel Syndrome: a frequent, invalidating, long-term complication of chronic haemodialysis.Clin Nephrol1984; 21: 98.
22.
AnelliA., BrancaccioD.. L'osteopatia da Beta-2 amiloidosi.Ital J Mineral Electrol Metab1991; 5: 41.
23.
FarinelliA., BedaniP.L., OrzincoloC.Amiloidisi da dialisi: quadro clinico e radiologico.Giorn It Nefrol1988; 5: 99.
24.
FlugeJ., GranollerasC., BingelM.. Beta 2 microglobulin kinetics during haemodialsyis and haemofiltration.Nephrol Dial Transpl1987; 1: 223.
25.
FloegeJ., SchafferJ., KochK.M., ShaldonS.. Dialysis related amyloidosis: a disease of chronic retention and inflammation?Kidney Int1992; 42(sup 38): 78.
26.
CobbyM.J., AdlerR.S., SwartzR., MartelW.. Dialysis related amyloid arthropathy: MR findings in four patients.Am J Rad1991; 157: 1023.
27.
BlumbergA., BurgiW.. Behaviour of Beta 2 microglobulin in patients with chronic renal failure undergoing haemodialysis, haemofiltration, and continuous ambulatory peritoneal dialysis (CAPD).Clin Nephrol1987; 27: 245.
28.
DratwaM., BergmanP., TielemansC.. Less Beta 2-microglobulin in CAPD than in haemodialysis. Abstract of the Xth Int. Congress Nephrol. London 1987; 188.
29.
SethiD., and GowerP.E.. Dialysis arthropathy, Beta 2 microglobulin and the effect of dialyser membrane.Nephrol Dial Transpl1988; 3: 768.
ScalamognaA., ImbasciatiE., De VecchiA.Beta 2 microglobulin in patients on Peritoneal Dialysis and Haemodialysis.Perit Dial Intern1989; 9: 37.
33.
MistriC.D., O'DonoghueD.J., NelsonS.. Kinetic and clinical studies of B2MG in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymers.Nephrol Dial Transpl1990; 5: 513.
34.
SteinG., SchauerS.T., SussJ.Influence of membranes on generation of Beta 2 M and release of leucocyte lysosomal enzymes.Int J Artif Organs1990; 6: 359.
35.
GanaduM., CherchiG.L., CampusA.M.Livelli plasmatici di Beta 2 microglobulina in pazienti in emodialisi: il ruolo della membrana dialitica in uno studio cross-over.Gior It Nefrol1989; 6: 29.
36.
GaffiG., BordoniE., LombardoV., MicucciG., MioliV.. Livelli sierici della Beta 2 microglobulina e sindrome del tunnel carpale (CTS) in patienti trattati con diverse metodiche dialitiche.Aula Med1989; 2: 147.
